Hatchtech Pty Ltd is an innovative biotechnology company developing novel solutions for everyday health problems based in Melbourne, Australia. Its lead development product, Xeglyze™ Lotion (formerly DeOvo™ Lotion), is a single dose, single treatment, topical prescription product for the control of head lice. The treatment works by killing both the lice and the eggs in one application. While existing head lice treatments treat the lice, few are highly effective against the eggs hence repeat applications and ‘nit combing’ are needed to eliminate an infestation. Additionally, whilst head lice have developed resistance to many of the current products on the market, the novel mode of action of Xeglyze™ effectively means resistance is unlikely to develop.
Something looks off?